Events
Stay current.
Get connected.
Whether it’s a statewide summit on the state of our industry or a gathering of HR professionals, Life Science Washington events help you expand your network and your knowledge, and grow your business.
Upcoming Events
Life Science Innovation Northwest 2026
Life Science Innovation Northwest is the Pacific Northwest’s largest annual life science conference bringing together investors, public and private life science organizations, research institutions, scientists, entrepreneurs, and the global health community for a two-day event to discuss and feature some of the most compelling technology breakthroughs of our time.
2026 Cell Signaling Breakthroughs Symposium
The 2026 Cell Signaling Breakthroughs Symposium brings 120+ experts to explore advances in cell signaling biology and therapeutic innovations The second annual 2026 Cell Signaling Breakthroughs Symposium will take place at the Renaissance Seattle Hotel. The event will provide an exceptional platform for academic leaders, biotech professionals, and scientists to engage with cutting-edge discoveries and […]
Lights, Data, Action: The Future of Bioscience & Healthcare
Evergreen Bioscience Innovation Cluster (Evergreen Bio), in partnership with the Coeur d’Alene Area Economic Development Corporation (CDA EDC), invites you to a movie premier–themed event spotlighting the upcoming Bioscience & Healthcare Industry Assessment for the Inland Northwest. This engaging, data-driven evening will unveil early insights from the draft assessment, highlighting the region’s current assets, workforce pipeline, and opportunities for […]
Executive Insights Series – Life Sciences Finances: Keys for Attracting Investment – From Series A to IPO
Founded in 2011, Absci has grown from a basement lab at Portland State University’s business accelerator into a publicly traded leader in AI-driven drug discovery. Under founder and CEO Sean McClain, the company progressed from a 2016 Series A to a 2021 IPO on NASDAQ with a $2B market cap, and now operates from an […]
Venture Investment and Partnership (VIP) Forum with Johnson & Johnson
Johnson & Johnson is advancing transformative innovation across drug discovery, drug development, data science, and digital health to accelerate the delivery of breakthrough therapies. Our approach is grounded in deep biological insight and an appreciation of disease complexity, enabling the development of novel, differentiated medicines. We leverage broad expertise across modalities—including small molecules, multispecific antibodies, […]
BIO International Convention
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from around the world. BIO 2026 is where we return to our essential “why.” It is our opportunity to reconnect as a global community, to recharge our commitment, and to remember that behind […]
Venture Investment and Partnership (VIP) Forum with Daiichi Sankyo
Join us for a high-impact Venture Investor & Partnering (VIP) Forum with Daiichi Sankyo, a global pharmaceutical leader with roots in Japan and operations spanning more than 30 countries. With over 120 years of scientific expertise, Daiichi Sankyo combines a rich legacy of innovation with a robust pipeline of promising new medicines. The company is […]